Advertisement
Advertisement
May 11, 2010
Cook Initiates European Study of Zenith TX2 TAA Graft
May 12, 2010—Cook Medical (Bloomington, IN) announced the commencement of its European clinical investigation of the Zenith TX2 low-profile thoracic aortic aneurysm (TAA) graft, with the first implants of the device performed by Professor Piotr Kasprzak, MD, at the University Hospital Regensburg, Germany. One patient was treated for a TAA measuring approximately 10 cm in diameter, and the other patient was treated for an ulcer that was notable for narrow access vessel anatomy (measuring approximately 5 mm in diameter). Up to 10 medical centers in Europe may take part in the TX2 low-profile TAA study.
According to Cook, at 16- and 18-F sizes, the TX2 low-profile delivery system is smaller than a standard TX2 device and is engineered to allow patients with challenging anatomies to be treated percutaneously. As a result, patients such as those with narrowed, small, or tortuous arteries, who previously may not have been suited for thoracic endovascular repair, may now benefit from minimally invasive treatment.
Advertisement
Advertisement
